Possibilities and prospects of using biofluorescent proteins at the stage of preclinical evaluation of live vaccines, using the example of the <i>Yersinia pestis</i> vaccine strain EV NIIEG pTURBOGFP-B
Introduction. Currently, studies aimed at finding the most informative and optimized method for assessing the survival rate of the plague microbe vaccine strain in the body of animals vaccinated against plague are relevant. Aim — to evaluate the feasibility of using biofluorescent proteins using...
Saved in:
Main Authors: | Svetlana N. Klyueva, Angelina A. Budanova, Aleksandr L. Kravtsov, Svetlana A. Bugorkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2025-05-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.crie.ru/jour/article/viewFile/18827/1591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancement of the Yersinia pestis EV NIIEG Vaccine Srain Immunogenic and Protective Activity under Cultivation with Azoxymer Bromide (Polyoxidonium)
by: T. N. Shchukovskaya, et al.
Published: (2022-01-01) -
Effect of Azoximer Bromide on Individual Genomic and Proteomic Characteristics of the Strain during Cultivation of <i>Yersinia pestis</i> EV NIIEG
by: A. Yu. Goncharova, et al.
Published: (2024-10-01) -
Proteins of the plague microbe vaccine strain (<i>Yersinia pestis</i> EV NIIEG) with potential allergen properties
by: V. V. Sutyagin, et al.
Published: (2020-01-01) -
Increased expression of tyrosine protein phosphatase (CD45) on the surface of human blood granulocytes under the influence of the plague microbe vaccine strain <I>Yersinia pestis</I> EV NIIEG <I>ex vivo</I> and <I>in vivo</I>
by: A. L. Kravtsov, et al.
Published: (2024-01-01) -
Use of azoximer bromide for treatment of children's inflammatory infections of respiratory system: a meta-analysis of controlled clinical studies
by: A. V. Karaulov, et al.
Published: (2019-12-01)